tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ENTO Stock Latest News

Entero Therapeutics Strikes Deal for Drug Trial Compliance Tech
Company AnnouncementsEntero Therapeutics Strikes Deal for Drug Trial Compliance Tech
10d ago
8K
ENTO
Entero Therapeutics signs letter of intent with Data Vault Holdings
PremiumThe Fly
Entero Therapeutics signs letter of intent with Data Vault Holdings
10d ago
ENTO
Entero Therapeutics receives noncompliance notification from Nasdaq
PremiumThe Fly
Entero Therapeutics receives noncompliance notification from Nasdaq
28d ago
ENTO
Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q
PremiumPress Releases
Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q
28d ago
ENTO
Entero Therapeutics Welcomes Timothy Ramdeen to Board
PremiumCompany Announcements
Entero Therapeutics Welcomes Timothy Ramdeen to Board
1M ago
8K
ENTO
Entero Therapeutics Grapples with Financial Strain and Compliance Issues
PremiumCompany AnnouncementsEntero Therapeutics Grapples with Financial Strain and Compliance Issues
1M ago
8K
ENTO
Entero Therapeutics Issues Shareholder Update Letter
Premium
Company Announcements
Entero Therapeutics Issues Shareholder Update Letter
2M ago
8K
ENTO
Entero Therapeutics chairman issues letter to stockholders
Premium
The Fly
Entero Therapeutics chairman issues letter to stockholders
2M ago
ENTO
Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program
PremiumPress Releases
Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program
2M ago
ENTO
Entero Therapeutics files to sell 3.53M shares of common stock for holders
PremiumThe Fly
Entero Therapeutics files to sell 3.53M shares of common stock for holders
2M ago
ENTO
Entero Therapeutics CSO Resigns Amid Cost-Cutting Strategy
PremiumCompany Announcements
Entero Therapeutics CSO Resigns Amid Cost-Cutting Strategy
2M ago
8K
ENTO
Entero Therapeutics announces exercise of warrants, issuance of new warrants
PremiumThe Fly
Entero Therapeutics announces exercise of warrants, issuance of new warrants
2M ago
ENTO
Entero Therapeutics Announces Abstract on Celiac Disease Research Accepted for Presentation at the 20th International Celiac Disease Symposium
PremiumPress ReleasesEntero Therapeutics Announces Abstract on Celiac Disease Research Accepted for Presentation at the 20th International Celiac Disease Symposium
2M ago
ENTO
Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease
Premium
Press Releases
Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease
3M ago
ENTO
Entero Therapeutics’ novel algorithm for celiac disease featured in publication
Premium
The Fly
Entero Therapeutics’ novel algorithm for celiac disease featured in publication
3M ago
ENTO
Entero Therapeutics Executive Team Strategic Reshuffle
PremiumCompany Announcements
Entero Therapeutics Executive Team Strategic Reshuffle
3M ago
8K
ENTO
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
PremiumPress Releases
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
4M ago
ENTO
Entero Therapeutics presents two posters on celiac disease research at DDW 2024
PremiumThe Fly
Entero Therapeutics presents two posters on celiac disease research at DDW 2024
4M ago
ENTO
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference
PremiumPress Releases
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference
4M ago
ENTO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >